Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ocular Therapeutix

7.71
-0.1900-2.41%
Post-market: 7.710.00000.00%16:05 EDT
Volume:1.71M
Turnover:13.22M
Market Cap:1.23B
PE:-6.31
High:7.96
Open:7.79
Low:7.62
Close:7.90
Loading ...
May 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 24, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
May 07, 2024

Major Issues Report

Form 8-K - Current report
Apr 18, 2024

Major Issues Report

Form 8-K - Current report
Mar 29, 2024

Major Issues Report

Form 8-K - Current report
Mar 11, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 11, 2024

Major Issues Report

Form 8-K - Current report
Mar 11, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Feb 22, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities